Melior Discovery
1 known investors
Melior is a contract research organization providing in vivo pharmacology services and phenotypic screening for the pharmaceutical industry, with a catalog of over 150 validated rat and mouse disease models across 14 therapeutic areas. It specializes in drug repositioning and indications discovery, offering both standard and custom animal models of human disease.
Investors Β· 1
Frequently asked questions
- What does Melior Discovery do?
- Melior is a contract research organization providing in vivo pharmacology services and phenotypic screening for the pharmaceutical industry, with a catalog of over 150 validated rat and mouse disease models across 14 therapeutic areas. It specializes in drug repositioning and indications discovery, offering both standard and custom animal models of human disease.
- Who are Melior Discovery's investors?
- Melior Discovery's investors include BioAdvance.